NOX 4.17% 6.9¢ noxopharm limited

Ann: New Independent Trial Data Supports Potential of Veyonda, page-6

  1. 438 Posts.
    lightbulb Created with Sketch. 211
    This sort of announcement does nothing for the company’s credibility imo.
    ’warmth’ isn’t even their study - and they’ve put it in a price sensitive document, and headline claim it supports Veyonda; unbelievable!!
    this sort of comparison of survivals between totally different studies is completely invalid. 71% increased survival ? Seriously?
    really poor stuff imo


 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.9¢
Change
-0.003(4.17%)
Mkt cap ! $20.16M
Open High Low Value Volume
6.9¢ 6.9¢ 6.9¢ $310 4.492K

Buyers (Bids)

No. Vol. Price($)
1 67971 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 8810 1
View Market Depth
Last trade - 14.16pm 29/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.